Study of the Correlation Between Muscle Oxygenation and Motor Function in Children With Neuromuscular Disease.

NCT ID: NCT03471676

Last Updated: 2021-12-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-03-26

Study Completion Date

2019-05-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Preliminary data underline the fact that muscular deoxygenation during training happens earlier in adult patients suffering from neuromuscular disorders in comparison to controls. Up to date, pediatric data are lacking.

The study aims at demonstrating if a correlation exists between the motor deficiency and the muscular deoxygenation in children suffering from neuromuscular disorders.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Preliminary data underline the fact that muscular deoxygenation during training happens earlier in adult patients suffering from neuromuscular disorders in comparison to controls, as it was demonstrated in Becker muscular dystrophy patients and fascioscapulo humeral muscular dystrophy. Moreover, the deoxygenation kinetics was positively correlated to the functional status and the muscular deficiency severity. However, no pediatric study has been conducted on this topic up to date.

The aim of the study is to determine if a correlation exists in children suffering from neuromuscular diseases:

* between muscular oxygenation and the percentage of the 6 minutes walking test performed in the routine medical care
* between muscular oxygenation and the total and D1 motor function measure value

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuromuscular Diseases in Infants Neuromuscular Diseases in Children

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Muscular oximetry

6 minutes walking test performed in the routine medical care with muscle oximetry recording in children suffering from neuromuscular diseases

Muscular oximetry

Intervention Type OTHER

6 minutes walking test performed in the routine medical care with muscle oximetry recording

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Muscular oximetry

6 minutes walking test performed in the routine medical care with muscle oximetry recording

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children from 6 to 18 years-old suffering from a neuromuscular disorder
* Able to walk, with or without help

Exclusion Criteria

* Hypoxia secondary to heart or lung disease
* Visual impairment (\<5/10)
* Parents refusal concerning data storage
Minimum Eligible Age

6 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Tours

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emmanuelle LAGRUE, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Tours

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital, Tours

Tours, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017-A02931-52

Identifier Type: OTHER

Identifier Source: secondary_id

17.11.07

Identifier Type: OTHER

Identifier Source: secondary_id

RIPH3-RNI17/OXMNM

Identifier Type: -

Identifier Source: org_study_id